Search Results

You searched for : empagliflozin  

	CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure. ... May 20
	US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction Latest Pharma News Update... Aug 23
	Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type ... Jan 07
	Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial ... Nov 19
	Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets Empagliflozin and Linagliptin tablets, have an estimated market size of US$ 244 million for twelve months ending June 2020... Aug 27
	Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets Alembic receives USFDA approval for their erectile dysfunction drug ... Aug 05
	USFDA gives tentative nod to Zydus for Empagliflozin tablets The medication is used to improve blood sugar control in adults with Type 2 diabetes mellitus, along with diet and exercise.... Apr 13
	Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors Post-hoc analysis of the EMPA-REG OUTCOME® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ... Sep 20
8 Matching result(s) found!

Trending Now
	The Value of Risk Communication in Public HealthOctober 08, 2026
	What Makes a Reliable Health Screening Programme?October 08, 2026
	How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
	Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
	Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
	Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
	How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
	AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
	AI and Patient Consent in India: Who Is Responsible?October 06, 2026
	Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
	Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
	Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
	Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
	Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
	Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
	Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
	Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
	Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
	The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
	Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026